Effect of Bevacizumab Intrapleural Perfusion on Patients with Malignant Pleural Effusion and Its Effect on Serum VEGF, CEA and Cyfra21-1

TAN Jin; LI Wenwei; ZHOU Shaofen

doi:10.14033/j.cnki.cfmr.2022.32.009

Home>Articles>Effect of Bevacizumab Intrapleural Perfusion on Patients with Malignant Pleural Effusion and Its Effect on Serum VEGF, CEA and Cyfra21-1

DOI: 10.14033/j.cnki.cfmr.2022.32.009

Effect of Bevacizumab Intrapleural Perfusion on Patients with Malignant Pleural Effusion and Its Effect on Serum VEGF, CEA and Cyfra21-1

TAN Jin

LI Wenwei

ZHOU Shaofen

Machine-generated Keywords：

Publication Date：2022-11-15

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 34-37 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2022,20(32)